What if zero-Covid fails in China? | Pendal Group
Hi there! Welcome to the new look Pendal website... Take a two minute tour to see what we’ve changed.

Mainstream Online Web Portal

Investors can view their accounts online via a secure web portal. After registering, you can access your account balances, periodical statements, tax statements, transaction histories and distribution statements / details.
Advisers will also have access to view their clients’ accounts online via the secure web portal.

What if zero-Covid fails in China?

Markets have not priced in the possibility of a large, uncontrolled Covid outbreak in mainland China, argues Pendal senior credit analyst TERRY YUAN. Here Terry outlines how that scenario would impact investors

CHINA’S zero-Covid policy is one of the most important under-the-radar issues facing investors.

While most countries have accepted the need to live with Covid, China has decided that uncontrolled spread within its borders is too dangerous.

The impact of China’s Covid policy on markets over the next few years could be widespread, affecting inflation, interest rates, currencies and equity sectors.

Given the extreme transmissibility of Omicron (and potential future variants) as well as the outbreak in Hong Kong, we believe the market has not priced in the possibility of a large uncontrolled outbreak in mainland China.

If there is a big outbreak China’s reaction will likely be swift and heavy handed, including lockdowns, mass testing and stimulus:

  • Travel restrictions would remain tight, limiting immigration and associated capital flows into Australia and the rest of the world. The more successful the zero Covid bubble, the more likely Chinese citizen would stay at home for tourism and education (much as Australians did over the past two years). We can assume this would limit supply of labour and put upward pressure on wages, inflation and interest rates. 

  • A bounce-back among Australian travel and immigration companies could be delayed given the dollar-weighted importance of Chinese immigration

  • Lockdowns, quarantines and hospitalisations would impact Chinese workers at factories, services firms and infrastructure providers. This would create bottlenecks in shipping and production, leading to more inflation.

  • Stimulus via fiscal and monetary easing — while the rest of the world was doing the opposite — would put pressure on Chinese interest rates.

China’s zero Covid policy could put upward pressure on wages, inflation and interest rates — and negatively impact sectors reliant on tourism and immigration over the next few years.

This means Australian investors should keep a close eye on airport, airline, hotel and education-related related companies in their portfolios.

Another consideration might be staying away from companies that lack pricing power.

At Pendal, we are carefully weighing this as one possible future scenario.

After navigating the initial Covid sell-off, post-pandemic rally and recent inflation spike, we are constantly looking for the next thing flying under the radar.

We are carefully selecting exposures to companies that have less exposure to China’s zero Covid policy, but have strong earnings stability, balance sheet strength and sustainability credentials. 

Pendal Sustainable Australian Fixed Interest Fund

An Aussie bond fund that aims to outperform its benchmark while targeting environmental and social outcomes via a portion of its holdings.

Why China persists with Covid-zero

Why does China refuse to let Covid like the rest of the world? 

The answer seems to be a combination of issues:

1. China is more vulnerable

Most of the Chinese population has been vaccinated with lower efficacy traditional inactivated viruses, rather than newer, higher efficacy MRNA vaccines.

Higher population density compared to the rest of the non-Asian world could increase the speed of transmission and more quickly overwhelm the Chinese hospital system.

Healthcare infrastructure in China, even in urban areas, is inferior to Australian standards, notes Pendal’s head of income Amy Xie Patrick

Even if Omicron infections result in a lower rate of hospitalisation relative to prior variants, the absolute numbers would likely overwhelm the hospital system.

Meanwhile, China does not want to rely on US vaccines given geopolitical tensions and potential for the US to threaten a ban on exports of MRNA vaccine supply (as it did with computer chips).

China wants to foster a successful domestic COVID vaccine and pharmaceutical industry for domestic security and a future international export avenue.

2. Political stability and timing

The Omicron wave hit at a particularly sensitive time for China — just before the Beijing Winter Olympics and Chinese New Year, the biggest holiday of the Chinese calendar.

Uncontrolled spread in Chinese cities would have captured global headlines as a failure of the Chinese government.

This would be playing on Chinese leader Xi Jinping’s mind as he approaches the Communist Party National Congress later this year, where he will seek an unprecedented third five-year term.

The last two leaders (Jiang and Hu) only had two terms before being forced to retire.

Positions on various Chinese ruling bodies will also be up for grabs. Uncontrolled Covid would likely hurt the incumbent. 

3. Social contract

Without elections, China’s top leaders understand they must deliver a growing standard of living for most citizens.

Otherwise, the recent Hong Kong riots could spring up all over China. Ubiquitous camera phones would likely capture any heavy handed crackdown by the government.

Every Chinese leader has studied how and why dynasties and governments failed in China’s 2000-year history.

Confucian society centres on the family unit and respecting elders. An elevated hospitalisation or death rate for the elderly would leave a deep scar and resentment for the government.

Find out about

Regnan Credit Impact Trust

When might China abandon its zero COVID policy?

China could abandon its zero-Covid policy when a domestic pharmaceutical champion successfully develops a higher efficacy vaccine or treatment and begins manufacturing the product at scale. 

Alternatively, after Xi Jinping’s re-election China could authorise foreign-produced vaccines with higher efficacy (eg Pfizer or Moderna) for a mass domestic booster campaign.

This would allow China to abandon its zero-Covid policy and gradually reopen to the world in 2023.


About Terry Yuan and Pendal’s Income & Fixed Interest boutique

Terry is a senior credit analyst with Pendal’s Income and Fixed Interest team

Terry has extensive experience in buy-side and sell-side fixed income, consulting and accounting. He has previously worked at Antares Fixed Income and Morgan Stanley. 

He is a Chartered Financial Analyst (CFA) and has been admitted as a solicitor in NSW, Australia.

Pendal’s Income and Fixed Interest boutique is one of the most experienced and well-regarded fixed income teams in Australia.

The team won Lonsec’s Active Fixed Income Fund of the Year award in 2021 and Zenith’s Australian Fixed Interest award in 2020.

Find out more about Pendal’s fixed interest strategies here


About Pendal Group

Pendal is an independent, global investment management business focused on delivering superior investment returns for our clients through active management.

Contact a Pendal key account manager


This information has been prepared by Pendal Fund Services Limited (PFSL) ABN 13 161 249 332, AFSL No 431426 and is current as at February 24, 2022.

PFSL is the responsible entity and issuer of units in the Regnan Credit Impact Trust (Trust) ARSN: 638 304 220 and Pendal Sustainable Australian Fixed Interest Fund (Fund) ARSN: 612 664 730. A product disclosure statement (PDS) is available for the Funds and can be obtained by calling 1300 346 821 or visiting www.pendalgroup.com. The Target Market Determination (TMD) for the Fund and Trust are available at www.pendalgroup.com/ddo. You should obtain and consider the PDS and the TMD before deciding whether to acquire, continue to hold or dispose of units in the Fund.

An investment in the Fund or Trust or any of the funds referred to in this web page is subject to investment risk, including possible delays in repayment of withdrawal proceeds and loss of income and principal invested.

This information is for general purposes only, should not be considered as a comprehensive statement on any matter and should not be relied upon as such. It has been prepared without taking into account any recipient’s personal objectives, financial situation or needs. Because of this, recipients should, before acting on this information, consider its appropriateness having regard to their individual objectives, financial situation and needs. This information is not to be regarded as a securities recommendation.

The information may contain material provided by third parties, is given in good faith and has been derived from sources believed to be accurate as at its issue date. While such material is published with necessary permission, and while all reasonable care has been taken to ensure that the information is complete and correct, to the maximum extent permitted by law neither PFSL nor any company in the Pendal group accepts any responsibility or liability for the accuracy or completeness of this information.

Performance figures are calculated in accordance with the Financial Services Council (FSC) standards. Performance data (post-fee) assumes reinvestment of distributions and is calculated using exit prices, net of management costs. Performance data (pre-fee) is calculated by adding back management costs to the post-fee performance. Past performance is not a reliable indicator of future performance.

Any projections are predictive only and should not be relied upon when making an investment decision or recommendation. Whilst we have used every effort to ensure that the assumptions on which the projections are based are reasonable, the projections may be based on incorrect assumptions or may not take into account known or unknown risks and uncertainties. The actual results may differ materially from these projections.

For more information, please call Customer Relations on 1300 346 821 8am to 6pm (Sydney time) or visit our website www.pendalgroup.com

Keep updated
Sign up to receive the latest news and views